Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MANE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
MANE
Veradermics, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
MANE
Veradermics, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
MANE
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▼
−1.63%
—
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
= implied
MANE realized, solid
LLY realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
MANE
Veradermics, Inc
Change
139.81
▼
−2.81%
· post 139.01
Mkt cap
$5.6B
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,412.87
▲
+2.85%
· post 1,417.05
Closed
Oct 30 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Oct 30 '26
MANE
Veradermics, Inc
vs
LLY
ELI Lilly & Co
139.81
▼
−2.81%
post 139.01
Price
1,412.87
▲
+2.85%
post 1,417.05
$5.6B
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
MANE
139.81
▼
−2.81%
vs
LLY
1,412.87
▲
+2.85%
Closed
Oct 30 '26